Your browser doesn't support javascript.
loading
Third-line Pyrotinib, Trastuzumab (Zercepac®) and Vinorelbine for brain metastases of HER2-positive advanced breast cancer patient.
Wang, Huan; Shao, Bin; DI, Lijun.
Affiliation
  • Wang H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Shao B; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • DI L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China - dilijun2012@163.com.
Minerva Med ; 2022 Jul 05.
Article in En | MEDLINE | ID: mdl-35785951
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Minerva Med Year: 2022 Document type: Article Affiliation country: China Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Minerva Med Year: 2022 Document type: Article Affiliation country: China Country of publication: Italy